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Background: Previous studies suggest that people who consume alcohol and drugs are at increased risk 
of Sexually Transmitted Infections (STIs).  We examined the prevalence and predictors of self-reported 
STI testing and diagnosis among self-reported regular ecstasy users (REU). Methods: 955 REU from the 
2011 and 2012 Ecstasy and Related Drugs Reporting System were included in the analysis. Bivariate and 
multivariate Poisson regression was used to identify predictors of recent STI testing and logistic 
regression was used to identify predictors of recent STI diagnosis. Results: Forty-four percent of REU 
reported having a recent STI test and five percent reported a recent diagnosis. Of the 421 REU who 
reported a recent test, 10% reported a recent STI diagnosis.   In multivariable analysis, REU were more 
likely to report a recent STI test if they were female compared to males (RR=1.56; 95% CI=1.36-1.80), 
aged 25-29 years compared to 16-19 years (RR=1.34; 95% CI=1.05-1.72), and reported ≥2 casual sex 
partners compared to no casual partners (RR=1.48; 95% CI=1.01-2.14). REU reporting cannabis use in 
the past six months were 0.78 times less likely to report a recent STI test (95% CI=0.66-0.94). There were 
no significant predictors associated with STI diagnosis. Conclusion: Encouragingly, REU who reported 
having multiple casual partners in the past six months were more likely to report a recent test. However, 
younger REU aged 16-19 years were least likely to test suggesting health promotion need to be directed 
to this age group. Further research is required to explain the lower testing among cannabis users. 
 









Sexually transmitted infections (STIs) can cause significant morbidity among young people; untreated 
infections can lead to infertility, organ damage and cancers[1-4]. STI prevalence is increasing; for 
example chlamydia notifications increased from 130 notifications per 100,000 population in 2001 to 435 
notifications per 100,000 population in 2011 [4]. The use of alcohol and other drugs can impair 
judgement which can lead to greater risk taking behaviours which subsequently put people at greater 
risk of STIs [5-7]. The aim of this paper is to identify demographic and behavioural predictors associated 




Up to 100 participants from the Ecstasy and Related Drug Reporting System (EDRS) from the eight 
Australian capital cities were recruited in 2011 and 2012 for a one hour face-to-face interview 
comprising questions on drug use, sexual behaviour and health. Eligible participants reported regular 
ecstasy use (defined as use on at least six occasions) in the past six months, were aged 16 years or older 
and had resided in their capital city for at least 12 months prior to interview. Ethical approval was 
obtained from each jurisdiction. Two key outcomes were examined, reports of recent STI testing and STI 
diagnosis (within the past 12 months). For the latter outcome (recent STI diagnosis), only regular ecstasy 
users (REU) who reported a recent STI test were included. Surveys were excluded if, in 2012, 
participants indicated they had participated in previous year to retain unique observations[8]. Further 
details of the EDRS study have been reported elsewhere[9]. 
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Bivariate and multivariable Poisson regression with robust error variance were used to identify factors 
associated with recent STI testing (reported as risk ratios). Bivariate and multivariable logistic regression 
models were used to identify factors associated with recent STI diagnosis (reported as odds ratios) 
among REU who reported a recent test. Multivariable models included all predictor variables selected 
for analysis. Variables included in the analysis were gender, age, sexual orientation, income, 
employment, that have been shown to be related to testing rates or diagnosis along with sex risk 
behaviours (number of casual, defined as anyone who is not a regular partner, sex partners in the past 
six months, number of times they had sex with a casual partner under the influence of drugs in the past 
six months) and different types of drugs used in the past six months (stimulants, cannabis, opioids, 
benzodiazepines, other pharmaceuticals and hallucinogens)[2, 7, 10, 11].  
 
RESULTS 
Nine hundred and fifty five REU were included in the analysis; 44% reported having a recent STI test (in 
the 12 months prior to interview) and 5% reported a recent diagnosis. 
In multivariable analysis, factors associated with reporting a recent STI test included being female, being 
aged 25-29 years (compared to being aged 16-19 years), and reporting ≥2 casual sex partners in the past 
six months (compared to no casual sex partners reported). REU reporting cannabis use in the past six 
months were less likely to report a recent STI test compared to those who did not report cannabis use. 
Of the 421 REU who reported a recent STI test, 10% reported a recent STI diagnosis. There were no 
significant associations between any of the predictor variables and STI diagnosis among those tested 






In our study, 44% of REU reported a recent STI test and were more likely to report a recent STI test if 
they were female, aged 25-29 years, reported two or more casual sex partners in the past six months 
and if they did not report using cannabis in the past six months. However, we found no significant 
associations between predictor variables and STI diagnosis among those who reported a recent STI test.  
While questions about specific STIs were asked in the questionnaire, they were poorly completed 
(n=177) and therefore we were not able to ascertain which STI REU were tested for. There are no 
comparable data available for overall STI testing in the Australian population. However, the rate of 
testing among females (57%) was comparable to female cervical screening rates (primarily for HPV) in 
the general population (57%)[3], suggesting female REU were comparable to the broader female 
population to some extent. Males reported a testing rate of 38%, much higher than that found in the 
general population for chlamydia testing in 2008[12].    The finding that female REU were more likely to 
report an STI test compared to males may derive from more frequent health seeking behaviour among 
females (thereby providing general practitioners more opportunities to offer a test[13, 14]) or the fact 
that testing recommendations related to STIs such as cervical cancer screening are female-targeted [3].  
REU aged 25-29 years were more likely to report a recent STI test compared to REU aged 16-19 years. 
This may reflect a lack of knowledge about STIs among young people aged under 20 years, which is 
commonly reported [15, 16].  This suggests the need for targeting education efforts towards younger 
people. Indeed, early education is important to prevent significant disease sequelae such as infertility or 
cancer that progress from long-term untreated infections[3, 17].  
Reporting two or more casual sex partners in the past six months was associated with more frequent 
reports of STI testing, consistent with findings in the wider population, in spite of the differences in 
temporality of the testing (past 12 months) and sex partners (past six months) questions[18]. 
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Nevertheless, our analysis is limited by the fact that we did not collect information on other types of 
relationships for analysis (i.e. concurrent relationships, sex work). Few variations were evident in testing 
behaviour as a function of the use of different drugs, with the exception of reduced testing among those 
who reported recent cannabis use.  This effect of cannabis use was independent of other behaviours 
such as the reported number of casual sex partners and needs further investigation. 
While our findings present an encouraging picture of STI testing among REU, further work is needed to 
better understand testing rates and diagnoses according the variety of STIs. Further work is also needed 
to understand the relationship between reported cannabis use and less frequent testing to determine 
whether those REU who use cannabis should be targeted for intervention.  
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Table 1. Factors associated with recent STI testing among REU, 2011-2012 
    Bivariate Multivariable 
  n (%) % tested RR 95% CI RR 95% CI 
Total  955 (100) 44     
Gender 
Male 639 (67) 38 1.00  1.00  
Female 316 (33) 57 1.49* 1.30-1.71 1.56* 1.36-1.80 
Sexual orientation 
Heterosexual 843 (88) 43 1.00  1.00  
Non-heterosexual 112 (12) 55 1.29* 1.07-1.55 1.10 0.90-1.34 
Age group (years) 
16-19 192 (20) 36 1.00  1.00  
20-24 436 (46) 46 1.25* 1.01-1.55 1.21 0.98-1.49 
25-29 179 (19) 49 1.35* 1.06-1.71 1.34* 1.05-1.72 
30+ 148 (16) 45 1.24 0.96-1.61 1.28 0.99-1.67 
Employment 
No 304 (32) 47 1.00  1.00  
Yes 651 (68) 43 0.93 0.80-1.08 0.92 0.79-1.08 
Weekly income 
≤$400 492 (52) 44 1.00  1.00  
>$400 463 (48) 45 1.03 0.90-1.19 1.00 0.86-1.17 
Number of casual sex 
partners, past six 
months^ 
None 300 (31) 37 1.00  1.00  
One 149 (16) 34 0.93 0.71-1.21 0.95 0.64-1.41 
2+ 506 (53) 52 1.40* 1.18-1.66 1.48* 1.01-2.14 
Number of times had sex 
with casual partner 
under the influence of 
drugs, past six months^ 
None 351 (37) 38 1.00  1.00  
One 57 (6) 44 1.17 0.84-1.61 1.11 0.72-1.70 
2-5 287 (30) 48 1.29* 1.08-1.54 1.01 0.70-1.44 
6+ 260 (27) 49 1.31* 1.09-1.57 1.00 0.70-1.42 
Used stimulants other 
than ecstasy~ 
No 141 (15) 38 1.00  1.00  
Yes 814 (85) 45 1.19 0.95-1.48 1.15 0.91-1.44 
Used Cannabis~ No 152 (16) 54 1.00  1.00  
Yes 803 (84) 43 0.79* 0.67-0.93 0.78* 0.66-0.94 
Used Opioids~ No 753 (79) 43 1.00  1.00  
Yes 202 (21) 49 1.14 0.96-1.34 1.13 0.96-1.34 
Used Benzodiazepines~ No 600 (63) 42 1.00  1.00  
Yes 355 (37) 49 1.16* 1.01-1.34 1.10 0.94-1.27 
Used other 
pharmaceuticals~ 
No 851 (89) 43 1.00  1.00  
Yes 104 (11) 52 1.19 0.98-1.46 1.06 0.86-1.31 
Used Hallucinogens~ No 464 (49) 42 1.00  1.00  
Yes 491 (51) 46 1.09 0.94-1.26 1.11 0.96-1.28 
Hazardous alcohol 
drinking^^ 
No 89 (9) 44 1.00  1.00  
Yes 866 (91) 44 1.01 0.79-1.30 1.06 0.83-1.35 
^ Casual sex partners refer to anyone who is not a regular partner. 
~used drugs in the past six months 





Table 2. Factors associated with recent STI diagnosis among REU who recently tested, 2011-2012 
    Bivariate Multivariable 
  n (%) % 
diagnosed 
RR 95% CI RR 95% CI 
Total  421 (100) 10     
Gender 
Male 241 (57) 11 1.00  1.00  
Female 180 (43) 9 0.86 0.45-1.64 0.81 0.41-1.60 
Sexual orientation 
Heterosexual 360 (86) 10 1.00  1.00  
Non-heterosexual 61 (15) 13 1.40 0.62-3.19 1.44 0.58-3.57 
Age group (years) 
16-19 70 (17) 13 1.00  1.00  
20-24 197 (47) 12 0.90 0.39-2.04 0.86 0.36-2.05 
25-29 88 (21) 8 0.59 0.21-1.66 0.62 0.20-1.91 
30+ 66 (16) 6 0.44 0.13-1.50 0.41 0.11-1.55 
Employment 
No 141 (33) 9 1.00  1.00  
Yes 280 (67) 11 1.18 0.60-2.34 1.47 0.67-3.21 
Weekly income 
≤$400 212 (50) 11 1.00  1.00  
>$400 209 (50) 10 0.87 0.46-1.64 0.79 0.37-1.68 
Number of casual sex 
partners, past six 
months^ 
None 111 (26) 6 1.00  1.00  
One 51 (12) 4 0.61 0.12-3.03 0.46 0.05-4.13 
2+ 259 (62) 13 2.25 0.96-5.23 2.34 0.41-13.35 
Number of times had sex 
with casual partner 
under the influence of 
drugs, past six months^ 
None 132 (31) 7 1.00  1.00  
One 24 (6) 17 2.73 0.77-9.72 2.42 0.35-16.56 
2-5 139 (33) 9 1.29 0.53-3.17 0.73 0.14-3.87 
6+ 126 (30) 14 2.28 0.98-5.28 1.21 0.23-6.24 
Used stimulants other 
than ecstasy~ 
No 54 (13) 9 1.00  1.00  
Yes 367 (87) 10 1.13 0.43-3.01 1.13 0.38-3.32 
Used Cannabis~ No 82 (19) 12 1.00  1.00  
Yes 339 (81) 10 0.78 0.37-1.64 0.63 0.26-1.52 
Used Opioids~ No 324 (77) 10 1.00  1.00  
Yes 97 (23) 11 1.17 0.56-2.41 1.26 0.57-2.78 
Used Benzodiazepines~ No 250 (59) 11 1.00  1.00  
Yes 171 (41) 9 0.76 0.39-1.47 0.75 0.37-1.53 
Used other 
pharmaceuticals~ 
No 367 (87) 10 1.00  1.00  
Yes 54 (13) 11 1.11 0.45-2.78 1.07 0.40-2.84 
Used Hallucinogens~ No 197 (47) 10 1.00  1.00  
Yes 224 (53) 10 1.01 0.54-1.91 0.99 0.47-2.05 
Hazardous alcohol 
drinking^^ 
No 39 (9) 10 1.00  1.00  
Yes 382 (91) 10 0.99 0.34-2.95 1.03 0.31-3.45 
^ Casual sex partners refer to anyone who is not a regular partner. 
~used drugs in the past six months 
^^AuditC scores ≥5 are considered hazardous.  
 
 
